B. Schlemmer
University of Paris
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by B. Schlemmer.
Critical Care Medicine | 2000
Elie Azoulay; Sylvie Chevret; Ghislaine Leleu; Frédéric Pochard; M. Barboteu; Christophe Adrie; Pierre Canouï; J. R. Le Gall; B. Schlemmer
ObjectiveEffective communication of simple, clear information to families of intensive care unit (ICU) patients is a vital component of quality care. The purpose of this study was to identify factors associated with poor comprehension by family members of the status of ICU patients. DesignProspective study. SettingUniversity-affiliated medical intensive care unit. Patients and MethodsA total of 102 patients admitted to an ICU for >2 days. InterventionThe representatives of 76 patients who were visited by at least one person during their ICU stay were interviewed. ResultsMean patient age was 54 ± 17 yrs and mean Simplified Acute Physiology Score II at admission was 40 ± 20. The representative was the spouse in 47 cases (62%). Among representatives, 25 (33%) were of foreign descent and 12 (16%) did not speak French. Mean duration of the first meeting with a physician was 10 ± 6 mins. In 34 cases (54%), the representative failed to comprehend the diagnosis, prognosis, or treatment of the patient.Factors associated with poor comprehension by representatives included patient-related, family-related, and physician- related factors. Patient-related factors included age <50 yrs (p = .03), unemployment (p = .01), referral from a hematology or oncology ward (p = .006), admission for acute respiratory failure (p = .005) or coma (p = .01), and a relatively favorable prognosis (p = .04). Family-related factors were foreign descent (p = .007), no knowledge of French (p = .03), representative not the spouse (p = .03), and no healthcare professional in the family (p = .01). Physician-related factors were first meeting with representative <10 mins (p = .03) and failure to give the representative an information brochure (p = .02). Moreover, after the first meeting, caregivers accurately predicted poor comprehension by representatives (p = .03). ConclusionsPatient information is frequently not communicated effectively to family members by ICU physicians. Physicians should strive to identify patients and families who require special attention and to determine how their personal style of interrelating with family members may impair communication.
Intensive Care Medicine | 2000
Elie Azoulay; Delphine Moreau; Corinne Alberti; Ghislaine Leleu; Christophe Adrie; M. Barboteu; P. Cottu; Vincent Levy; J. R. Le Gall; B. Schlemmer
Abstract Admission of cancer patients with serious medical complications to the ICU remains controversial primarily because of the high short-term mortality rates in these patients. However, the cancer patient population is heterogeneous regarding age, underlying conditions, and curability of their disease, suggesting that large variations may occur in the effectiveness of intensive care within this subgroup of critically ill patients.¶Objectives: To identify factors predicting 30-day mortality in patients with solid tumors admitted to a medical ICU.¶Patients and methods: We conducted a retrospective study in 120 consecutive cancer patients (excluding patients with hematological malignancies) admitted to the medical ICU of a 650-bed university hospital between January 1990 and July 1997. Medical history, physical and laboratory test findings at admission, and therapeutic interventions within the first 24 h in the ICU were recorded. The study endpoint was vital status 30 days after ICU admission. Stepwise logistic regression was used to identify independent prognostic factors.¶Results: The observed 30-day mortality rate was 58.7 % (n = 68), with most deaths (92 %) occurring in the ICU. Univariate predictors of 30-day mortality were either protective [prior surgery for the cancer (p = 0.01) and complete remission (p = 0.01)] or associated with higher mortality [Knaus scale C or D (p = 0.02), shock (p = 0.04), need for vasopressors (p = 0.0006) or for mechanical ventilation (p = 0.0001), SAPS II score greater than 36 (p = 0.0001), LOD score greater than 6 (p = 0.0001), and ODIN score > 2 (p = 0.0001)]. Three variables were independent predictors: previous surgery for the cancer (OR 0.20, 95 % CI 0.07–0.58), LOD score > 6 (OR 1.26, 95 % CI 1.09–1.44), and need for mechanical ventilation (OR 3.55, 95 % CI; 1.26–6.7). Variables previously thought to be indicative of a poor prognosis (i. e., advanced age, metastatic or progressive disease, neutropenia or bone marrow transplantation) were not predictive of outcome.¶Conclusion: When transfer to an ICU is considered an option by patients and physicians, 30-day mortality is better estimated by an evaluation of acute organ dysfunction than by the characteristics of the underlying malignancy.
Intensive Care Medicine | 1999
Elie Azoulay; Christian Recher; Corinne Alberti; Lilia Soufir; Ghislaine Leleu; J. R. Le Gall; J. P. Fermand; B. Schlemmer
Objective: Intensivists generally view patients with hematological malignancies as poor candidates for intensive care. Nevertheless, hematologists have recently developed more aggressive treatment protocols capable of achieving prolonged complete remissions in many of these patients. This change mandates a reappraisal of indications for ICU admission in each type of hematological disease. Improved knowledge of the prognosis is of assistance in making treatment decisions. Patients and methods: The records of 75 myeloma patients consecutively admitted to our ICU between 1992 and 1998 were reviewed retrospectively and predictors of 30-day mortality were identified using stepwise logistic regression. Results: The median age was 56 years (37–84). Chronic health status (Knaus scale) was C or D in 39 cases. Fifty-five patients (73 %) had stage III disease and 17 had a complete or partial remission. Autologous bone marrow transplantation had been performed in 28 patients (37 %). ICU admission occurred between 1992 and 1995 in 41 patients (54.7 %), and between 1996 and 1998 in 34 patients (45.3 %). The median SAPS II and LOD scores were 60 (23–107) and 7 (0–21), respectively. Reasons for ICU admission were acute respiratory failure in 39 patients (52 %) and shock in 31 (41 %). Forty-six patients (61 %) required mechanical ventilation. Fifty patients (66 %) received vasopressors and 24 dialysis. Thirty-day mortality was 57 %. Only five parameters were independently associated with 30-day mortality in the multivariate model: female gender (OR = 5.12), mechanical ventilation (OR = 16.7) and use of vasopressor agents (OR = 5.67) were associated with a higher mortality rate, whereas disease remission (OR = 0.16) and ICU admission between 1996 and 1998 (OR = 0.09) were associated with a lower one. Conclusion: The prognosis for myeloma patients in the ICU is improving over time. This may reflect either recent therapeutic changes in hematological departments and ICUs or changes in patient selection for ICU admission. Hematologists and intensivists should work closely together to select hematological patients likely to benefit from ICU admission.
Annals of the Rheumatic Diseases | 1992
B. Godeau; Azzedine Boudjadja; Jean François Dhainaut; B. Schlemmer; C. L. Chastang; F. Brunet; J.-R. Le Gall
The outcome of patients admitted to intensive care units is known to be influenced by such factors as age, previous health status, severity of disease, and diagnosis. To estimate the outcome of such patients with systemic rheumatic diseases and to determine if the severity of these diseases unfavourably influences the prognosis at the time of admission to a medical intensive care unit, the clinical courses of all patients with systemic rheumatic disease admitted to two medical intensive care units between January 1978 and December 1988 were studied retrospectively. Sixty nine patients with systemic lupus erythematosus (n = 16), necrotising vasculitis (n = 19), rheumatoid arthritis (n = 19), and other systemic rheumatic diseases (n = 15) were included. The mean (SD) age on admission into the medical intensive care unit was 53 (17) years and the mean simplified acute physiological score was 12 (5.5). The principal diagnoses on admission were infectious complications (29/69 patients) and acute exacerbation of the systemic rheumatic disease (19/69 patients). The death rate in the medical intensive care unit was 33% (23/69 patients) and was similar to that of a non-selected population with comparable simplified acute physiological score. The death rate in hospital was 42% (29/69 patients). Infection was the main cause of death in the medical intensive care unit (19/23 patients) and the infection was mainly acquired in the unit. Only the simplified acute physiological score on admission was a statistically significant prognostic factor: the simplified acute physiological score in patients who died was 15 (5.2) v 9.9 (4.7) for survivors. Long term outcome analysis showed that 83% (33/40 patients) of patients were still alive after admission to the medical intensive care unit with a follow up time between two months and nine years (mean 38 months). The death rate was relatively high and was mainly due to nosocomial infections. It was not different, however, from that of nonselected patients and the long term prognosis was highly favourable. This shows that the complications are often reversible, particularly infectious applications, and justifies admission to the medical intensive care unit of this group of patients.
American Journal of Respiratory and Critical Care Medicine | 1997
Maité Garrouste-Orgeas; Sylvie Chevret; G. Arlet; Olivier Marie; M. Rouveau; N. Popoff; B. Schlemmer
Intensive Care Medicine | 2003
Elie Azoulay; Frédéric Pochard; Sylvie Chevret; Charles Arich; François G. Brivet; Frédéric Brun; Pierre-Emmanuel Charles; Thibaut Desmettre; Didier Dubois; Richard Galliot; Maité Garrouste-Orgeas; Dany Goldgran-Toledano; Patrick Herbecq; Luc-Marie Joly; Mercé Jourdain; Michel Kaidomar; Alain Lepape; Nicolas Letellier; Olivier Marie; Bernard Page; Antoine Parrot; Pierre-André Rodie-Talbere; Alain Sermet; Alain Tenaillon; Marie Thuong; Patrick Tulasne; Jean-Roger Le Gall; B. Schlemmer
Chest | 2001
Elie Azoulay; Habiba Attalah; Alain Harf; B. Schlemmer; Christophe Delclaux
Critical Care | 2000
Frédéric Pochard; Elie Azoulay; Sylvie Chevret; François Lemaire; Philippe Hubert; Pierre Canouï; Jr Le Gall; Jean François Dhainaut; B. Schlemmer
Medecine Et Maladies Infectieuses | 1994
J.R. Le Gall; Christian Brun-Buisson; B. Leclercq; B. Schlemmer; J.P. Sollet; Michel Wolff
Nouvelle revue française d'hématologie | 1993
B. Schlemmer; Hervé Dombret; Ghislaine Leleu; Maité Garrouste; J.-R. Le Gall